From: Expenditure and resource utilisation for cervical screening in Australia
Age group (years) | Cytology test conducted for primary routine screening†,††| Cytology test conducted for follow-up of low-grade abnormalities††,‡ | Cytology test conducted as part of "test-of-cure" management after treatment for high-grade CIN††| Overall annual number of cytology test (No. of test conducted for routine screening or follow-up of low-grade abnormalities)‡‡ | Annual cost related to cytology testing (cost related to cytology test conducted for routine screening or follow-up of low-grade abnormalities) | % total | |||
---|---|---|---|---|---|---|---|---|---|
No. of tests‡‡ | Related cost | No. of tests‡‡ | Related cost | No. of tests‡‡ | Related cost | ||||
<20 | 17,800 | $1.0 M | 600 | $32,900 | 60 | $3,900 | 19,100 (18,400) | $1.1 M ($1.1 M) | 1% |
20-24 | 167,100 | $9.7 M | 20,000 | $1.2 M | 4,100 | $0.3 M | 201,600 (187,000) | $11.2 M ($10.9 M) | 9% |
25-29 | 166,900 | $9.7 M | 28,700 | $1.7 M | 10,500 | $0.7 M | 215,900 (195,600) | $12.1 M ($11.4 M) | 10% |
30-49 | 784,200 | $45.7 M | 91,300 | $5.2 M | 76,300 | $5.1 M | 981,800 (875,400) | $56.0 M ($50.9 M) | 47% |
50-69 | 482,700 | $28.1 M | 44,500 | $2.6 M | 61,200 | $4.1 M | 600,000 (527,200) | $34.8 M ($30.7 M) | 29% |
70+ * | 41,300 | $2.4 M | 3,900 | $0.2 M | 8,300 | $0.6 M | 54,800 (45,200) | $3.2 M ($2.6 M) | 3% |
20-69 | 1,600,900 | $93.2 M | 184,400 | $10.6 M | 152,200 | $10.2 M | 1,999,200 (1,785,300) | $114.1 M ($103.9 M) | 96% |
0-84 | 1,660,000 | $96.7 M | 188,900 | $10.9 M | 160,600 | $10.8 M | 2,073,100 (1,848,900) | $118.3 M ($107.5 M) | 100% |